Europe Needles Market – Industry Trends and Forecast to 2030

Europe Needles Market Analysis and Size

The growing incidence rate of cancer is making way for the market's growth as immense surgeries, and treatment processes use different needles. Also, due to the incidence of diabetes, insulin requirement is on the rise, enhancing the market's growth rapidly. The use of needle-free injection technology is increasing by physicians and healthcare providers which is letting to more adoptuion of the same and in a way growing the market growth.

Data Bridge Market Research analyses a growth rate in the needles market in the forecast period 2023-2030. The expected CAGR of the needles market tends to be around 7.50% in the mentioned forecast period. The market is valued at USD 2,421.86 million in 2022 and will grow to USD 4,319.33 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Europe Needles Market Scope and Segmentation

Market Definition

Needles are the kind of injectable devices widely used with injections to offer medications to the body. They are also widely used to collect samples, inject numerous pharmaceutical drugs into the body, and are adjusted in syringes. The needles are of several types and sizes used widely for samples, injections, and sutures. They are used through two major routes hypodermic and intravenous. Some major types include safety needles, intravenous needles, and winged needles.

Europe Needles Market Dynamics

Drivers

• Increasing Prevalence of Diabetes

Around 60 million people have diabetes in the European Region; about 10.3% are men, and 9.6% are women aged 25 years and above. Approximately 1 in 11 adults has diabetes. Around 36% of people living with diabetes are undiagnosed. The diabetic population requires insulin for lowering and controlling blood sugar levels, which is generally administered with the help of a syringe. Therefore, the growing incidence of diabetes will likely increase the market's growth.

• Growing Rate of Product Approvals from Organizations

There has been an increasing rate of product approvals from authorized organizations that boost market growth. For instance, Takeda received the United States Food and Drug Administration (U.S. FDA) approval for the TAKHZYRO injection single-dose prefilled syringe (PFS) in 2022 to prevent attacks of hereditary angioedema (HAE). Thus, these kinds of product approvals enhance the demand for needles and are expected to help the market growth in the region.

Opportunities

• Growing Number of Immunization Programs

The increasing number of immunization programs, especially after the pandemic, the rising adoption of COVID-19 vaccination, and the wide availability of needles are estimated to play a main role in the market's growth. For instance, with the current large-scale vaccination programs in this region, needles are being used on a large scale in delivering vaccines. Thus, the production of syringes has increased rapidly. Thus, this factor boosts the growth of the market.  

• Increasing Demand for Hypothermic Needles

The growing demand for hypothermic needles is accelerating market growth. A hypodermic needle is utilized for the quick delivery of liquids. It is also beneficial to deliver some medications that cannot be delivered orally because of vomiting. Hypodermic needles can be effective with a smaller diameter; hence, many patients prefer that as they have less vein damage and, consequently, lower amounts of pain. Thus, this factor increases the market growth.

Restraints/Challenges

• Complications Associated with Needle Stick Injuries

There have been rising complications associated with needle stick injuries that impede market growth. These injuries transmit infectious diseases, particularly blood-borne viruses. The different types include the Human Immunodeficiency Virus (HIV), which can cause AIDS (Acquired Immune Deficiency Syndrome), hepatitis B, and hepatitis C. Thus, this factor hinders the market growth.

This needles market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the needles market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2022, Roche diabetes care introduced ACCU-FINE pen needles for painless insulin delivery. The product assists in easier insulin delivery, thus leading to better diabetes management for people suffering from this disease

Europe Needles Market Scope

The needles market is segmented on the basis of type, product type, material, delivery mode, end users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Conventional
• Safety

Product Type

• Suture
• Blood Collection
• Ophthalmic
• Dental
• Insufflation
• Pen
• Others

Material

• Stainless Steel
• Plastic Needles
• Glass Needles
• Peek Needles

Delivery Mode

• Hypodermic Needles
• Intravenous Needles
• Intramuscular Needles
• Intraperitoneal Needles

End User

• Hospitals
• Diagnostic Centers
• Home Care
• Others

 Distribution Channel

• Direct Tender
• Retail Sales

Needles Market Regional Analysis/Insights

The needles market is analyzed and market size insights and trends are provided by type, product type, material, delivery mode, end users and distribution channel as referenced above.

The major countries covered in the needles market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany is anticipated to grow with the highest CAGR in the forecast period because of growing cases of chronic diseases and various research activities. The growing sedentary lifestyle of people, and requirement of many injection medications, presence of the highest number of elderly and vulnerable populations are all leading to the growth of the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Europe Needles Market Share Analysis

The needles market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to needles market

Key players operating in the needles market include:

• Medtronic (Ireland)
• Ethicon U.S., LLC. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Novo Nordisk A/S (Denmark)
• B.D. (U.S.)
• Stryker (U.S.)
• Boston Scientific Corporation (U.S.)
• Luminex Corporation (U.S.)
• Illumina, Inc (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• QIAGEN (Netherlands)
• Abcam plc (U.K.)
• Merck KGaA (Germany)
• Promega Corporation (U.S.)
• Siemens (Germany)
•  PerkinElmer, Inc. (U.S.)
• Shimadzu Corporation (Japan)  

SKU-66301